Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Geopolitical Risks Rise as Gaza Flotilla Activists Allege Mistreatment by Israeli Forces Dollar Slides as Oil Retreats on Strait of Hormuz Optimism Nvidias Earnings Reveal 200 Billion Edge Computing Opportunity Amid China Market Challenges Money Market Account Rates on May 24 2026 Top Account Offers 401 APY Amid Declining Yields Federal Reserve Faces Challenges in Justifying Rate Cuts as Cost of Living Pressures Intensify Arvinas Inc ARVN Q1 2026 Earnings Narrower Loss Beats Expectations as Clinical Pipeline Advances Iveda Solutions Q2 2024 Earnings EPS Surpasses Estimates Despite Minimal Revenue Data Zevia PBC ZVIA Q1 2026 Earnings Narrowerthanexpected loss drives stock surge IPWR Q1 2026 Earnings EPS Misses Estimates as Stock Declines 167 SKYE Q1 2026 Earnings EPS Slightly Below Estimates Stock Surges 16 on Strategic Progress Mohawk Industries MHK Gains 16 Testing Key Resistance Levels Amid Housing Sector Dynamics Veris Residential VRE Hovers Near Support With Minimal Movement Knife Riv Holding Co KNF Faces Pressure Key Support Levels Tested After 2 Decline Alpha Tau Medical DRTS Slides 84 as Shares Test Support Levels Michael Burry Warns SECs Blockchain Trading Plan Could Spell Trouble for Investors Kevin Warsh Faces Internal Fed Divisions Over Rate Cut Path as Inflation Pressures Persist Wall Street Analysts Weigh In on Regeneron Pharmaceuticals Potential Upside and Risks Bitcoin LongTerm Holder Supply Approaches Record 163 Million BTC Signal of Smart Money Accumulation Intercontinental Exchange ICE Edges Higher Amid Positive Volume Trends Power Solutions International PSIX Faces Selling Pressure as Key Support Levels Come into Focus Enlivex ENLV Shares Slide 467 as Stock Tests Key Support at 065 Grupo Televisa TV Edges Higher Key Levels to Watch After a Slight Rally Kratos Defense Security Solutions KTOS Edges Higher as Defense Sector Gains Momentum Definium Therapeutics DFTX Gains Ground as Stock Approaches Key Resistance Level